Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03199742 · ClinicalTrials.gov registry record · NA
Evaluation of a Mobile Phone App for Veterans With PTSD
A NA study of Stress Disorders, Post-Traumatic and Veterans, sponsored by VA Palo Alto Health Care System.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT03199742: Completed NA study of Stress Disorders, Post-Traumatic and Veterans, sponsored by VA Palo Alto Health Care System.
NCT03199742 is a NA study of Stress Disorders, Post-Traumatic and Veterans that has completed, run by VA Palo Alto Health Care System. The registered enrollment target is 101 participants, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03199742, a NA study of Stress Disorders, Post-Traumatic and Veterans, has completed, sponsored by VA Palo Alto Health Care System.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a mobile phone app designed to help Veterans with PTSD. Participants in this study will be randomized to receive one of 2 possible mobile phone apps. The term "randomized" means that which app a participant receives will not be based on any characteristic or behavior of the participant, but will be determined solely by chance like a flip of a coin.
Primary Outcome
Measures symptoms of post-traumatic stress disorder
Conditions Studied
Interventions
- BEHAVIORAL Active Comparator
- BEHAVIORAL Personalized App Coaching
Study Locations (1)
California
- VA Palo Alto Health Care System Menlo Park Division - Menlo Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
What the finished NCT03199742 record still lists
NCT03199742 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 155-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (35% lower).
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator is the first listed.
NCT03199742 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03199742 about?
NCT03199742 is a clinical study titled "Evaluation of a Mobile Phone App for Veterans With PTSD". The purpose of this study is to evaluate a mobile phone app designed to help Veterans with PTSD. Participants in this study will be randomized to receive one of 2 possible mobile phone apps. The term "randomized" means that which app a participant receives will not be based on any characteristic or ...
What is the current status of trial NCT03199742?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2017-07-01. Estimated completion is 2019-03-01.
What conditions does trial NCT03199742 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Veterans.
What interventions are being tested in trial NCT03199742?
The interventions under investigation include: Active Comparator (BEHAVIORAL), Personalized App Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03199742?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03199742 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03199742's enrollment target sits among peer trials
101 30th of 66 higher than 37 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI